PDCD1 and neoplasm: Huang et al70 reported that the T‐cell invigoration‐to‐tumor burden ratio was associated with anti‐PD‐1 response, and T‐cell invigoration could be monitored as low expression of Ki‐67 on circulating CD8 T cells.